Abstracts tagged "Polyarthritis and viruses"

Abstract Number: 1310 • 2016 ACR/ARHP Annual Meeting
Management of Chronic Post-Chikungunya Rheumatic Disease: The Martinican Experience
Marie Blettery¹, Lauren Brunier², JULIA MARY³, Katlyne Polomat⁴, Florence MOINET⁴, Christophe Deligny⁵, Serge ARFI⁶, Georges JEAN BAPTISTE⁷ and Michel De Bandt⁸, ¹rheumatology, CHU Fort de France, Fort de France, Martinique, ²CHUM de Martinique,, Unit of rheumatology, CHUM, 97200 Fort de France, France, ³RHEUMATOLOGY, CHU Fort de France, 97261, Martinique, ⁴Rheumatology and Internal Medicine, Zobda Quitman Hospital, Fort de France, Martinique, ⁵Zobda Quitman Hospital, Rheumatology and Internal Medicine, Fort de France, Martinique, ⁶University Hospital, CHU Fort de France, Fort de France, Martinique, ⁷RHEUMATOLOGY, CHU MARTINIQUE, FWI, Fort-de-France, Martinique, ⁸Rheumatology department, CHU Fort de France, Fort de France, France
Background/Purpose: To describe “chronic chikungunya (CHIK)” manifestations seen during the Caribbean outbreak from December 2013 to January 2015. Methods: We report our experience as the…
Abstract Number: 1315 • 2016 ACR/ARHP Annual Meeting
Methotrexate and TNF-Blockers for Post Chikungunya Chronic Arthritis : The Martinican Experience
Marie Blettery¹, Lauren Brunier-Agot², JULIA MARY³, Katlyne Polomat⁴, Florence MOINET⁴, Christophe Deligny⁵, Serge ARFI⁶, Georges JEAN BAPTISTE⁷ and Michel De Bandt⁸, ¹rheumatology, CHU Fort de France, Fort de France, Martinique, ²Internal medicine and rheumatology, Zobda Quitman Hospital, Fort de France, Martinique, ³RHEUMATOLOGY, CHU Fort de France, 97261, Martinique, ⁴Rheumatology and Internal Medicine, Zobda Quitman Hospital, Fort de France, Martinique, ⁵Zobda Quitman Hospital, Rheumatology and Internal Medicine, Fort de France, Martinique, ⁶University Hospital, CHU Fort de France, Fort de France, Martinique, ⁷RHEUMATOLOGY, CHU MARTINIQUE, FWI, Fort-de-France, Martinique, ⁸Rheumatology department, CHU Fort de France, Fort de France, France
Background/Purpose: To describe treatments in patients with chronic post-chikungunya polyarthritis seen during the Caribbean outbreak (December 2013 - January 2015). Methods: Patients were examined by…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].